Prognostic significance of adrenal gland morphology at CT in patients with three common malignancies

British Journal of Radiology

Volumn 85, Issue 1014, 2012, Pages 807-812

  Meehan, C P ^a   Fuqua III, J L ^a   Reiner, A S ^a   Moskowitz, C S ^a   Schwartz, L H ^a   Panicek, David M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BREAST CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROGNOSIS; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861909103     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/69444644     Document Type: Article

References (15)

1. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950;3:74-85.
2. Benitah N, Yeh BM, Qayyum A, Williams G, Breiman RS, Coakley FV. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer. Radiology 2005;235:517-22. (Pubitemid 40571090)
3. Brunt LM, Moley JF. Adrenal incidentaloma. World J Surg 2001;25:905-13. (Pubitemid 32666393)
4. Mittendorf EA, Lim SJ, Schacherer CW, Lucci A, Cormier JN, Mansfield PF, et al. Melanoma adrenal metastasis: natural history and surgical management. Am J Surg 2008;195:363-8; discussion 368-9.
5. Rajaratnam A, Waugh J. Adrenal metastases of malignant melanoma: characteristic computed tomography appearances. Australas Radiol 2005;49:325-9. (Pubitemid 41097972)
6. Montagne JP, Kressel HY, Korobkin M, Moss AA. Computed tomography of the normal adrenal glands. AJR Am J Roentgenol 1978;130:963-6. (Pubitemid 8327783)
7. Vincent JM, Morrison ID, Armstrong P, Reznek RH. Computed tomography of diffuse, non-metastatic enlargement of the adrenal glands in patients with malignant disease. Clin Radiol 1994;49:456-60. (Pubitemid 24229498)
8. Bishop MC, Ross EJ. Adrenocortical activity in disseminated malignant disease in relation to prognosis. Br J Cancer 1970;24:719-25.
9. Dobriner K, Lieberman S, Wilson H, Ekman B, Pearson O, Eliel L. Adrenal function and steroid excretion in neoplastic disease. In: Mote JR, ed. Proceedings of the first clinical ACTH conference. Philadelphia, PA: The Blakiston Co; 1950. pp. 158-67.
10. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 2000;175:1411-15.
11. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002;222:629-33. (Pubitemid 34215205)
12. Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV, et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2005;238:578-85. (Pubitemid 43134370)
13. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000;217:798-802.
14. Park BK, Kim CK, Kim B, Lee JH. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 2007;243:760-5. (Pubitemid 46799430)
15. Goldman SM, Kenney PJ. The adrenal glands. In: Lee JKT, Sagel SS, Stanley RJ, eds. Computed body tomography with MRI correlation, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 1310-73.